Original research
by
Slatkin, Neal E. et al
Release Date
2007
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
This study evaluated fentanyl buccal tablets for breakthrough pain in opioid-tolerant patients with chronic cancer pain.
Findings/Key points
FBT was efficacious, well tolerated, demonstrated rapid onset of analgesia (within 10 minutes), and had a sustained effect.
Design/methods
Randomized, double-blind, placebo-controlled design and was conducted at 30 outpatient treatment centers in the United States
Keywords
About prescribers
Chronic pain
